@natesumMRSA I think many different ARVs will end up working for PrEP. Obvi need specific studies. This study predicted that efavirenz, even at lower dose and w/ imperfect adherence would be pretty protective against WT and mutant viruses... https://t.co/b
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis https://t.co/taPw4F52Fw https://t.co/Kn5KMmwzbs
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis https://t.co/cGfs3RNDRv #pharmacology #openaccess
Studie sieht Potenzial des #HIV-Wirkstoffs #Efavirenz für die Prä-Expositions-Prophylaxe #PrEP. Allerdings wird HIV leicht gegen Efavirenz resistent. https://t.co/5THRz1i1qe